Poland· PL-100475070
Lutetium (177Lu) chloride Billev
A other therapeutic radiopharmaceuticals product containing lutetii chloridum [177lu], registered in Poland by Billev Pharma ApS. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lutetii chloridum [177lu] is registered in 8 of 19 countries.
Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Lutetii chloridum [177lu] · ATC V10X
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Lutetii chloridum [177Lu]
- Manufacturer
- Billev Pharma ApS
- Country
- Poland (PL)
- ATC code
- V10X
- ATC class
- OTHER THERAPEUTIC RADIOPHARMACEUTICALS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V10X
Other therapeutic radiopharmaceuticals, as other registers publish it.
- FinlandEndolucinBetaITM Medical Isotopes GmbH
- PolandEndolucinBetaITM Medical Isotopes GmbH
- IcelandEndolucinBetaITM Medical Isotopes GmbH
- DenmarkEndolucinBetaITM Medical Isotopes GmbH
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/88d261a7-1f60-4212-9095-8ad02354aa42 GET /v1/drugs/88d261a7-1f60-4212-9095-8ad02354aa42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prekursor radiofarmaceutyku, roztwór",
"source": "urpl",
"strength": "51,8 GBq/ml",
"packaging": "Rpz ¦ EU/1/22/1680/002 ¦ 147354\n2 fiol. 5 ml\nRpz ¦ EU/1/22/1680/005 ¦ 147355\n2 fiol. 10 ml\nRpz ¦ EU/1/22/1680/006 ¦ 147356\n3 fiol. 10 ml\nRpz ¦ EU/1/22/1680/004 ¦ 147357\n1 fiol. 10 ml\nRpz ¦ EU/1/22/1680/003 ¦ 147358\n3 fiol. 5 ml\nRpz ¦ EU/1/22/1680/001 ¦ 147359\n1 fiol. 5 ml",
"substance": "Lutetii (177Lu) Chloridum 51,8 GBq/ml",
"common_name": "Lutetii chloridum [177Lu]",
"pl_product_id": "100475070",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about lutetii chloridum [177lu].
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.